ALV Form 4: Martin Lundstedt receives 1,728.5767 RSUs with 2026 vesting
Rhea-AI Filing Summary
Martin Lundstedt, a director of Autoliv Inc. (ALV), was granted restricted stock units totaling 1,728.5767 on 09/23/2025. Each RSU represents a contingent right to one share of ALV common stock and the award shows 11.5121 underlying shares noted per unit grouping at a $0 price. Dividend equivalents were credited as additional RSUs under the same vesting schedule. The RSUs vest and convert to shares in one installment on the earlier of Autoliv's 2026 annual stockholder meeting or the one‑year anniversary of May 8, 2025. The Form 4 was signed by Brian Kelly by power of attorney on 09/24/2025.
Positive
- Grant disclosed: Reporting person received 1,728.5767 RSUs on 09/23/2025.
- Dividend equivalents: Cash dividends accrue as additional RSUs under the same vesting schedule.
- Clear vesting terms: RSUs vest on the earlier of the 2026 annual meeting or one‑year anniversary of May 8, 2025.
Negative
- None.
Insights
TL;DR Director received 1,728.5767 RSUs that vest by Autoliv's 2026 meeting or one year from May 8, 2025.
The disclosed grant is a non‑cash equity award recorded at $0 exercise price, with dividend equivalents accruing as additional RSUs. The disclosure is routine for director compensation and shows no cash purchase or disposition; the filing simply notifies the market of the issuance and the vesting schedule. There are no balance sheet, revenue, or debt impacts in this filing; effects are limited to potential future share issuance upon vesting.
TL;DR Standard director equity grant with a single‑installment vesting condition tied to the 2026 meeting or a one‑year anniversary.
The Form 4 describes customary restricted stock units with dividend equivalent treatment and a clear vesting trigger. The filing is a routine disclosure under Section 16 and indicates governance practice of awarding equity to a director. The use of a power of attorney signature is disclosed and consistent with procedural practice; no governance concerns or unusual terms are evident in the text provided.